192 related articles for article (PubMed ID: 12070601)
1. Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors.
Mawrin C; Kirches E; Boltze C; Dietzmann K; Roessner A; Schneider-Stock R
Virchows Arch; 2002 Jun; 440(6):610-5. PubMed ID: 12070601
[TBL] [Abstract][Full Text] [Related]
2. Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.
Thomas L; Mautner VF; Cooper DN; Upadhyaya M
Hum Genomics; 2012 Sep; 6(1):18. PubMed ID: 23244685
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
Agesen TH; Flørenes VA; Molenaar WM; Lind GE; Berner JM; Plaat BE; Komdeur R; Myklebost O; van den Berg E; Lothe RA
J Neuropathol Exp Neurol; 2005 Jan; 64(1):74-81. PubMed ID: 15715087
[TBL] [Abstract][Full Text] [Related]
4. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
[TBL] [Abstract][Full Text] [Related]
5. Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis.
Upadhyaya M; Spurlock G; Thomas L; Thomas NS; Richards M; Mautner VF; Cooper DN; Guha A; Yan J
Hum Mutat; 2012 Apr; 33(4):763-76. PubMed ID: 22331697
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of malignant triton tumors.
Strauss BL; Gutmann DH; Dehner LP; Hirbe A; Zhu X; Marley EF; Liapis H
Hum Pathol; 1999 Aug; 30(8):984-8. PubMed ID: 10452514
[TBL] [Abstract][Full Text] [Related]
7. [Expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and p53 protein and their significance in human hepatocellular carcinomas].
Cheng LM; Wang SY; Lin JS
Ai Zheng; 2003 Jan; 22(1):42-5. PubMed ID: 12561434
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
9. p53 expression in neurofibroma and malignant peripheral nerve sheath tumor. An immunohistochemical study of sporadic and NF1-associated tumors.
Halling KC; Scheithauer BW; Halling AC; Nascimento AG; Ziesmer SC; Roche PC; Wollan PC
Am J Clin Pathol; 1996 Sep; 106(3):282-8. PubMed ID: 8816583
[TBL] [Abstract][Full Text] [Related]
10. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors.
Birindelli S; Perrone F; Oggionni M; Lavarino C; Pasini B; Vergani B; Ranzani GN; Pierotti MA; Pilotti S
Lab Invest; 2001 Jun; 81(6):833-44. PubMed ID: 11406645
[TBL] [Abstract][Full Text] [Related]
11. p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children.
Liapis H; Marley EF; Lin Y; Dehner LP
Pediatr Dev Pathol; 1999; 2(4):377-84. PubMed ID: 10347283
[TBL] [Abstract][Full Text] [Related]
12. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).
Upadhyaya M; Kluwe L; Spurlock G; Monem B; Majounie E; Mantripragada K; Ruggieri M; Chuzhanova N; Evans DG; Ferner R; Thomas N; Guha A; Mautner V
Hum Mutat; 2008 Jan; 29(1):74-82. PubMed ID: 17960768
[TBL] [Abstract][Full Text] [Related]
13. Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions.
Zhou H; Coffin CM; Perkins SL; Tripp SR; Liew M; Viskochil DH
Am J Surg Pathol; 2003 Oct; 27(10):1337-45. PubMed ID: 14508395
[TBL] [Abstract][Full Text] [Related]
14. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.
Subramanian S; Thayanithy V; West RB; Lee CH; Beck AH; Zhu S; Downs-Kelly E; Montgomery K; Goldblum JR; Hogendoorn PC; Corless CL; Oliveira AM; Dry SM; Nielsen TO; Rubin BP; Fletcher JA; Fletcher CD; van de Rijn M
J Pathol; 2010 Jan; 220(1):58-70. PubMed ID: 19890883
[TBL] [Abstract][Full Text] [Related]
16. MDM2 amplification in malignant peripheral nerve sheath tumors correlates with p53 protein expression.
Wallander ML; Tripp S; Layfield LJ
Arch Pathol Lab Med; 2012 Jan; 136(1):95-9. PubMed ID: 22208493
[TBL] [Abstract][Full Text] [Related]
17. Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.
Kourea HP; Cordon-Cardo C; Dudas M; Leung D; Woodruff JM
Am J Pathol; 1999 Dec; 155(6):1885-91. PubMed ID: 10595919
[TBL] [Abstract][Full Text] [Related]
18. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization.
Mechtersheimer G; Otaño-Joos M; Ohl S; Benner A; Lehnert T; Willeke F; Möller P; Otto HF; Lichter P; Joos S
Genes Chromosomes Cancer; 1999 Aug; 25(4):362-9. PubMed ID: 10398430
[TBL] [Abstract][Full Text] [Related]
19. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
Perrone F; Tabano S; Colombo F; Dagrada G; Birindelli S; Gronchi A; Colecchia M; Pierotti MA; Pilotti S
Clin Cancer Res; 2003 Sep; 9(11):4132-8. PubMed ID: 14519636
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]